Skip to main content
. 2025 Jun 10;17(12):1925. doi: 10.3390/cancers17121925
BM Basement membrane
CAFs Cancer-associated fibroblasts
CK14 Cytokeratin 14
COL1A1 Collagen like type I
CTLA-4 Cytotoxic T-lymphocyte associated protein 4
CXCL14 Chemokine (C-X-C motif) ligand 14
DCIS Ductal carcinoma in situ
DCIS-Mi DCIS with microinvasion
DCs Dendritic cells
DFS Disease-free survival
ECM Extracellular matrix
EMT Epithelial–mesenchymal transition
ER Estrogen receptor
EZH2 Enhancer of zeste homolog 2
HDAC Histone deacetylases
HER2 Human epidermal growth factor 2
HR Hormone receptor
IDC Invasive ductal carcinoma
IL-6 Interleukin-6
lncRNA Long noncoding RNA
LSD1 Lysine-specific demethylase 1
MECs Myoepithelial cells
miRNA MicroRNA
MMP3 Matrix metalloproteinase-3
MSCs Mesenchymal stem cells
NK Natural killer
PD-1 Programmed cell death receptor 1
PD-L1 Programmed death-ligand 1
PR Progesterone receptor
PRC2 Polycomb repressive complex 2
SMMHC Smooth muscle myosin heavy chain
TAMs Tumor-associated macrophages
TCF7 T-cell factor 7
TGFβ1 Transforming growth factor beta 1
TIGIT T cell immunoreceptor with immunoglobulin and ITIM domain
TILs Tumor-infiltrating lymphocytes
TME Tumor microenvironment
TNBC Triple-negative breast cancer
Tregs Regulatory T cells
VEGF Vascular endothelial growth factor
α-SMA α-Smooth muscle actin